[ad_1]
Julio Croda, a specialist in infectious disease research at Fiocruz (Fundação Oswaldo Cruz), said he is concerned about the federal government’s organization to vaccinate the Brazilian population against covid-19. He said the Ministry of Health should give a clearer message about the purchase of immunizers. And he added that Brazil is “behind in everything”, including the purchase of materials for vaccination.
“The whole world is after supplies. It is not just Brazil. Syringes and needles are essential for vaccination. There will be competition in the market. We already saw it at the time of PPE (Personal Protective Equipment) and respirators, when We did not have immediate purchases and we could not offer more beds because of that. We may have a vaccine in March. But if that purchase (of supplies) is not successful due to lack of a supplier, we may have to postpone this vaccine, “he said. Croda in an interview with Globonews.
In my opinion, we are way behind on everything. This vaccine movement has been going on for six months. We knew that we would need syringes and needles regardless of the type of vaccine chosen.
July Croda, infectious researcher at Fiocruz
The federal government announced yesterday that it is negotiating the purchase of 70 million doses of the vaccine produced by Pfizer, in partnership with BioNTech. Julio Croda, however, believes that this move came “late”.
“Most of the countries involved signed a term of intention to purchase an expressive lot. And they have to do it in advance, because companies work with foresight. The Butantan Institute offered a larger number of doses to the Ministry of Health, which they thought was not necessary, “said Croda, recalling the controversy over CoronaVac – in October, the Ministry of Health even signed the intention to buy this vaccine, but the president Jair Bolsonaro (without a party) canceled the negotiation, after public discussions with the governor of São Paulo, João Doria (PSDB).
When asked about the PNE (State Vaccination Plan), released yesterday by Doria, Julio Croda said that the federal government must act in another way, to reassure state and municipal managers.
“With the announcement of the anticipation of vaccination in São Paulo for more than two months, this generates pressure on the federal government. States and municipalities are announcing purchases of specific vaccines. Pfizer asked for its release. If it is released, there is no impediment for states to acquire this entry, “Croda said.
“It is important that the ministry assumes this as soon as possible and makes it clear that if it has the vaccine approved by Anvisa [Agência Nacional de Vigilância Sanitária] Before March, you will buy as many lots as possible. This management must be clear to municipal managers ”, he said.
“Of course, it depends on the ability of the supplier to sell the vaccine as well. But if the federal government brings this simple message, that it is going to buy lots of vaccine approved by Anvisa, it gives the manager peace of mind, not to do parallel negotiations of no type of vaccine. “
The Fiocruz infectologist also commented on the start of vaccination against covid-19 in the United Kingdom, which occurred today, and was optimistic.
“It is the beginning of the end of the pandemic. We will need to vaccinate a large part of the population. The whole world is waiting for the vaccine. There is a delay. There was already a delay of the influenza vaccine, of six months, for it to arrive. the vaccine. poorer countries. But it is a hope and we have to believe in that hope, “concluded Croda.
Currently, four covid-19 vaccines are being tested in Brazil. Before being distributed and applied, they must be approved and registered by Anvisa.